'Predictions'Folks, everyone seems to be spending quite a bit of time and effort speculating, predicting, guessing, 'methodologizing', and otherwise attempting to 'put some numbers' on 'scenarios' of SP pricing behaviour/growth.
I think it's fair to say that if BioCloud gets absorbed by the market (especially if relatively quickly/soon) and people start to know about it in numbers / start 'demanding' it in public places, then it is only Blue Sky for this investment going forward?....
Whatever the number, it'll be HIGH IMO. With a ramp-up of sales then some 'precision' may begun to be put on valuation. Manufacturing capacity has been known for some time, and it has done very little arguably to affect valuation, since it speaks to capacity to supply the market, not actual units supplied or even known with some confidence WILL be supplied. 'Precision' is usualy not helpful in the absence of ACCURACY.
More information from the company would for sure be helpful in understanding what the short to mid-term picture is expected to look like. When people predict the long-term (in this context also referred to as the 'new normal' for air detection), keep in mind that to get to a 'long-term' (ie. for this new category, not the core business) there first needs to be a shorter window in which the product is established and conclusively 'adopted' by the market IMHO. And the best odds of that happening 'convincingly' are right now during the height of the covid debacle -- again, IMHO...
Sales and validation are critical right now IMHO. Advertising as I already mentioned is also IMHO critical right now. It's "GO TIME" right now for BioCloud and in terms of promo/advertising to the general public and communication re sales/validation to investors, I am hopeful that mgmt feels the same way and will begin to exhibit some more aggressive moves on all these fronts. Patience is indeed important, but in the absence of appropriate information (which includes 'actions') it begins to feel a lot like hope -- not patience.. GLTA...